SCHEDULE 13G/A 0001088875-21-000043 0001088875 XXXXXXXX LIVE 5 Common Stock 12/31/2024 0001760854 Nanobiotix S.A. 63009J107 60 RUE DE WATTIGNIES 60 RUE DE WATTIGNIES PARIS I0 75012 Rule 13d-1(b) BAILLIE GIFFORD & CO X0 1919670.00 0.00 1919670.00 0.00 1919670.00 4.1 IA Nanobiotix S.A. 60 RUE DE WATTIGNIES, 60 RUE DE WATTIGNIES, PARIS, FRANCE, 75012. Baillie Gifford & Co Calton Square 1 Greenside Row Edinburgh EH1 3AN Scotland UK Scotland N FI Investment Adviser 1,919,670 4.05 1,919,670 0.00 1,919,670 0.00 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Investment Adviser is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. BAILLIE GIFFORD & CO Grant Meikle 02/07/2025